NCT04320693Approved For Marketing不适用
Expanded Access for IMMU-132
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- Approved For Marketing
研究概览
简要总结
This is an expanded access program (EAP) for eligible participants designed to provide access to IMMU-132.
研究设计
- 研究类型
- Expanded Access
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
研究者
相似试验
No Longer Available
不适用
Expanded Access for MarizomibSolid TumorNCT04644107Celgene
No Longer Available
不适用
Expanded Access to Provide SUVN-502 for the Treatment of Subjects With Alzheimer's DiseaseAlzheimer DiseaseCognition DisordersDementiaNCT03564964Suven Life Sciences Limited
Available
不适用
A Cohort IND Expanded Access Program for Supporting Patient Access to TebentafuspUveal MelanomaNCT04960891Immunocore Ltd
No Longer Available
不适用
Expanded Access to EpcoritamabLymphomaNCT05692050AbbVie
No Longer Available
不适用
Expanded Access to Bimatoprost (Durysta)Open-angle GlaucomaNCT05338606AbbVie